Skip to main content

Table 1 Demographics and clinical characteristics of the study population

From: Baseline total metabolic tumor volume combined with international peripheral T-cell lymphoma project may improve prognostic stratification for patients with peripheral T-cell lymphoma (PTCL)

Characteristics Overall patients, n = 84
Sex
 Female/male 30/54
Age
 ≤ 60 years/> 60 years 43/41
LDH
 Normal/higher than normal 38/46
B symptoms
 No/yes 33/51
ECOG performance status
 0–1/> 1 57/27
Ann arbor stage  
 I–II/III–IV 15/69
Extranodal sites ≥ 2
 No/yes 65/19
BMB
 Negative/positive 63/21
Ki-67 ≥ 80%
 No/yes 60/24
Platelet cell count ≥ 150 × 109/L
 No/yes 48/36
IPI
 0–2/3–5 47/37
PIT
 0–1/2–4 41/43
IPTCLP
 0–1/2, 3 54/30
  1. LDH lactate dehydrogenase, ECOG PS Eastern Cooperative Oncology Group performance status, BMB bone marrow biopsy, IPI International Prognostic Index, PIT prognostic index for T-cell lymphoma, IPTCLP International peripheral T cell lymphoma Project